Abstract

Aim:Chronic Obstructive Pulmonary Disease(COPD) is an important mortality and morbidity reason and brings serious burdens to the economies of countries.We analyzed differences in examination,treatment and approach that may affect the economic burden of COPD in hospitalized patients with a diagnosis of COPD exacerbation in state and university hospitals Material and Methods:104 patients who were being treated in university hospital(UH) and 102 patients in State Hospital(SH) because of COPD were included.The difference in approach of physicians and cost analysis between two hospitals were compared Results and Conslusion:The average age was higher in SH(p=0,01).Comorbities were higher in UH(p<0.001).The number of patients who received nebulizer treatment(p=0,02) in UH and total number of nebulizer medication used was higher in SH(p<0,001).The number of patients for whom intravenous(IV) medication was used and the number of total IV medication used was higher in SH(p<0,001).The total number of IM medication used was higher in UH(p<0,001).The number oral antibiotics used was higher in UH(p<0,001).The penicillins,macrolids,penicillin-macrolids were used more in patients in UH.The cephalosporins and quinolons were used more in SH(p<0,001).Inhaler corticosteroid(ICS)(p<0,001),salbutamol+ipratropiumbromur combination in nebulizer form(p<0,001) and IV teophilin was used in more patients in SH(p=0,01).The use of salbutamol in nebulizer form was more in UH(p<0,001).Spirometry,arterial blood gas analysis(respectively p<0,001,p<0,001),chest radiography was applied more in UH(p=0,02).Total cost(p<0,001),total and daily medication costs was more in SH(p<0,001).Costs other than medication was more in UH(p=0,02).We believe that adherence to the guidelines has a very important effect on cost in patients hospitalized with COPD exacerbation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call